Anti-ganglioside antibodies in children with coeliac disease: Correlation with gluten-free diet and neurological complications

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 2, 2004, Pages 231-235

  Briani, C ^a   Ruggero, S ^a   Zara, G ^a   Toffanin, E ^a   Ermani, M ^a   Betterle, C ^a   Guariso, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GLUTEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

AGE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; EXPOSURE; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; PATIENT; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN RESTRICTION; SERUM;

ADOLESCENT; ANTIBODIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET, PROTEIN-RESTRICTED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULINS; INFANT; MALE;

EID: 3242883195     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02016.x     Document Type: Article

References (26)

1. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-8.
2. Cooke WT, Smith TW. Neurological disorders associated with adult coeliac disease. Brain 1966; 89: 683-722.
3. Burk K, Bosch S, Muller CA, et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 2001; 124: 1013-9.
4. Hadjivassiliou M, Grunewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 2002; 72: 560-3.
5. Papadatou B, DiCapua M, Gambarara M, et al. Nervous system involvement in paediatric celiac patients. In: Mearin, ML, Mulder, CJJ, eds. Coeliac Disease. Dordrecht: Kluwer Academic, 1991, 199.
6. Gobbi G, Bouquet F, Greco L, et al. Coeliac disease, epilepsy, and cerebral calcifications. Lancet 1992; 340: 439-43.
7. Taylor E, Scheffer IE, Berkovic SF. Occipital epilepsies: identification of specific and newly recognized syndromes. Brain 2003; 126: 753-69.
8. Alaedini A, Green PHR, Sander HW, et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol 2002; 127: 145-8.
9. Hadjivassiliou M, Boscolo S, Davies-Jones GAB, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002; 58: 1221-6.
10. Wiendl H, Mehling M, Dichgans J, Melms A, Burk K. The humoral response in the pathogenesis of gluten ataxia, Neurology 2003; 60: 1397.
11. Simonati A, Battistella PA, Guariso G, Clementi M, Rizzuto N. Coeliac disease associated with peripheral neuropathy in a child: a case report. Neuropediatrics 1998; 29: 155-8.
12. Polizzi A, Finocchiaro M, Parano E, Pavone P. Recurrent peripheral neuropathy in a girl with celiac disease. J Neurol Neurosurg Psychiatry 2000; 68: 104-5.
13. Latov N. Antibodies to glycoconjugates in neuropathy and motor neuron disease. Prog Brain Res 1994; 101: 295-303.
14. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk of autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999; 117: 297-303.
15. Lahat E, Broide E, Leshern M, Evans S, Scapa E. Prevalence of celiac antibodies in children with neurologic disorders. Pediatrie Neurology 2000; 22: 393-6.
16. Salur L, Uibo O, Talvik I, et al. The high frequency of coeliac disease among children with neurological disorders. Eur J Neurol 2000; 7: 707-11.
17. Bhat NM, Kantor AB, Bieber MM, et al. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int Immunol 1992; 4: 243-52.
18. Vader W, Kooy Y, Van Veelen P, et al. The gluten response in children with celiac disease is directed towards multiple gliadin and gluten peptides. Gastroenterology 2002; 122: 1729-37.
19. Ivarsson A, Hernell O, Nystrom L, Persson LA. Children born in the summer have increased risk for coeliac disease. J Epidemiol Community Health 2003; 57: 36-9.
20. Barbeau WE, Novascone MA, Elgert KD. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol Immunol 1997; 34: 535-41.
21. Wirguin I, Briani C, Suturkova-Milosevic L, et al. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J Neuroimmunol 1997; 78: 138-42.
22. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré syndrome and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37.
23. Kanda T, Iwasaki T, Yamawaki M, Tai T, Misuzawa H. Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model. Neurology 2000; 55: 585-7.
24. Meucci N, Baldini L, Cappellari A, et al. Anti-Myelin-Associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy. Ann Neurol 1999; 46: 119-22.
25. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 2517-24.
26. Freitag T, Schulze-Koops H, Niedobitek G, Melino G, Schuppan D. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmun Rev 2004; 3: 13-20.